I guess that 'worldwide roll out' mentioned this time was legit. So much more company and product credibility now that KT is selling the Actipatch (ie Recovery + Wave). Looks like this OEM strategy was the right decision. Jumping on the back of such a successful company with a marketing infrastructure already in place has made this 'worldwide roll out' easily fluid. Not hard for KT at all to add one more of their products (Rec + Wave) to all the others they are shipping and selling to existing clients in other countries.
Now we wait anxiously to see the name of who (distributor) will be getting the Recovery RX infiltrated in all medical centers for post operative treatment and wound healing.
(2)
(0)
BioElectronics Corporation (BIEL) Stock Research Links